SCHEMBL31680147

SCHEMBL31680147

CCOC(=O)/C=C/c1cc2c(cc1F)CN(C(=O)C(F)(F)F)CC2

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.47
▸ ESR2 Q92731 4/20 0.47
▸ PKM P14618 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ DPP4 P27487 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ MAP3K5 Q99683 1/20 0.34
▸ ABHD6 Q9BV23 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19643712 1.00 ESR1 (0.47) ESR1ESR2PKMALDH1A1DPP4
SCHEMBL20995813 0.83 ESR1 (0.51) ESR1ESR2PKMMEN1KMT2A
SCHEMBL20995812 0.83 ESR1 (0.51) ESR1ESR2PKMMEN1KMT2A
SCHEMBL4683432 0.82 ESR1 (0.54) ESR1ESR2PKMALDH1A1DPP4
SCHEMBL4683430 0.82 ESR1 (0.54) ESR1ESR2PKMALDH1A1DPP4
SCHEMBL19643709 0.77 ESR1 (0.46) ESR1ESR2PKMALDH1A1MEN1
SCHEMBL19643014 0.76 ESR1 (0.47) ESR1ESR2PKMALDH1A1DPP4
SCHEMBL31680211 0.76 ESR1 (0.47) ESR1ESR2PKMALDH1A1DPP4
SCHEMBL757937 0.72 CYP3A4 (0.51) ESR1PKMDPP4CYP3A4HSD17B1
SCHEMBL757936 0.72 CYP3A4 (0.51) ESR1PKMDPP4CYP3A4HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3463362-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME LLC (US) 2025-09-03 — — EP disclosed
Send feedback